ROC curve analysis indicated that the sensitivity and specificity of serum CEA for detecting lung cancer were 86.84% and 50.00%, while the sensitivity and specificity of the CD45+EpCAM+ cell ratio were 81.58% and 88.89%, respectively. This evidence concerns the gene EPCAM and lung carcinoma.